However, only a positive BRAF V600E outcome is considered valid, as the majority of follicular variant of papillary thyroid carcinoma (FVPTC) cases are BRAF V600E-negative. The gene discussed is BRAF; the disease is follicular variant thyroid gland papillary carcinoma.